Taylor, Kathryn R. http://orcid.org/0000-0002-5110-8703
Barron, Tara
Hui, Alexa
Spitzer, Avishay http://orcid.org/0000-0001-6551-9338
Yalçin, Belgin http://orcid.org/0000-0001-9689-9062
Ivec, Alexis E.
Geraghty, Anna C.
Hartmann, Griffin G. http://orcid.org/0000-0001-9213-8995
Arzt, Marlene
Gillespie, Shawn M.
Kim, Yoon Seok
Maleki Jahan, Samin
Zhang, Helena http://orcid.org/0000-0003-1873-9762
Shamardani, Kiarash http://orcid.org/0000-0002-2548-705X
Su, Minhui http://orcid.org/0000-0001-5803-6098
Ni, Lijun
Du, Peter P.
Woo, Pamelyn J.
Silva-Torres, Arianna
Venkatesh, Humsa S. http://orcid.org/0000-0003-1194-3015
Mancusi, Rebecca http://orcid.org/0000-0002-4809-5569
Ponnuswami, Anitha
Mulinyawe, Sara
Keough, Michael B.
Chau, Isabelle http://orcid.org/0000-0003-3733-4760
Aziz-Bose, Razina
Tirosh, Itay http://orcid.org/0000-0001-5477-2987
Suvà, Mario L. http://orcid.org/0000-0001-9898-5351
Monje, Michelle http://orcid.org/0000-0002-3547-237X
Article History
Received: 1 November 2021
Accepted: 26 September 2023
First Online: 1 November 2023
Competing interests
: M.M. was on the scientific advisory board for Cygnal Therapeutics, is on the scientific advisory board for TippingPoint Biosciences, and holds equity in MapLight Therapeutics. M.L.S. is an equity holder, scientific co-founder and advisory board member of Immunitas Therapeutics. The other authors declare no competing interests.